Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines
Continue Reading
From , Authored by: Ellen Braunstein...Across Northeast Ohio health systems, philanthropy is doing more than supplementing...
Continue Reading
New preclinical study from Harrington Discovery Institute at University Hospitals and Case Western Reserve University published in Cell Reports
Continue Reading
Scientists have created the largest molecular map of autism, identifying over 1,800 protein interactions that could revolutionize future treatment strategies.
Continue ReadingIn addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See All DiscoveriesBy concentrating philanthropic, scientific, and business development resources during the high-risk stages of drug development, Harrington ‘de-risks’ therapeutic candidates and positions them for further investment and commercialization.
Learn More